CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 4 filers reported holding CATALYST PHARMACEUTICALS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $483 | -25.2% | 41,320 | -14.1% | 0.02% | -20.0% |
| Q2 2023 | $646 | -23.6% | 48,075 | -5.7% | 0.02% | -28.6% |
| Q1 2023 | $845 | -11.2% | 50,981 | -0.3% | 0.04% | -16.7% |
| Q4 2022 | $952 | -99.9% | 51,158 | -17.2% | 0.04% | +35.5% |
| Q3 2022 | $793,000 | +45.0% | 61,821 | -20.8% | 0.03% | +93.8% |
| Q2 2022 | $547,000 | -15.3% | 78,019 | +0.2% | 0.02% | +6.7% |
| Q1 2022 | $646,000 | +6.8% | 77,886 | -12.9% | 0.02% | +25.0% |
| Q4 2021 | $605,000 | +28.2% | 89,407 | +0.5% | 0.01% | +9.1% |
| Q3 2021 | $472,000 | -11.6% | 88,990 | -4.1% | 0.01% | +10.0% |
| Q2 2021 | $534,000 | +109.4% | 92,810 | +67.5% | 0.01% | +100.0% |
| Q1 2021 | $255,000 | – | 55,399 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANAKA CAPITAL MANAGEMENT INC | 252,199 | $749,000 | 2.35% |
| MANGROVE PARTNERS IM, LLC | 3,031,965 | $9,005,000 | 1.14% |
| ARMISTICE CAPITAL, LLC | 10,000,000 | $29,700,000 | 1.08% |
| GABLES CAPITAL MANAGEMENT INC. | 432,864 | $1,286,000 | 0.83% |
| Worth Venture Partners, LLC | 268,682 | $798,000 | 0.66% |
| XTX MARKETS LLC | 18,749 | $56,000 | 0.27% |
| Capital Impact Advisors, LLC | 203,133 | $603,000 | 0.18% |
| Wealthspire Advisors, LLC | 337,770 | $1,003,000 | 0.06% |
| ROYCE & ASSOCIATES LP | 1,784,890 | $5,301,000 | 0.06% |
| XML Financial, LLC | 40,000 | $119,000 | 0.04% |